Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.

Article Details

Citation

Copy to clipboard

Lin J, Guo J, Gang H, Wojciechowski P, Wigle JT, Zhang S

Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.

Mol Pharmacol. 2005 Sep;68(3):855-65. Epub 2005 Jun 20.

PubMed ID

15967876 [ View in PubMed

]

Abstract

Many commonly used medications can cause long QT syndrome and thus increase the risk of life-threatening arrhythmias. High-affinity human Ether-a-go-go-related gene (HERG) potassium channel blockade by structurally diverse compounds is almost exclusively responsible for this side effect. Understanding drug-HERG channel interactions is an important step in avoiding drug-induced long QT syndromes. Previous studies have found that disrupting HERG inactivation reduces the degree of drug block and have suggested that the inactivated state is the preferential state for drug binding to HERG channels. However, recent studies have also shown that inactivation does not dictate drug sensitivity of HERG channels. In the present study, we examined the effect of inactivation gating on cisapride block of HERG. Modulation of HERG inactivation was achieved by either changing extracellular K+ or Cs+ concentrations or by mutations of the channel. We found that although inactivation facilitated cisapride block of the HERG K+ current, it was not coupled with cisapride block of HERG when the Cs+ current was recorded. Furthermore, cisapride block of the HERG K+ current was not linked with inactivation in the mutant HERG channels F656V and F656M. Our results suggest that inactivation facilitates cisapride block of HERG channels through affecting the positioning of Phe-656.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Cisapride	Potassium voltage-gated channel subfamily H member 2	Protein	Humans	Unknown	Inhibitor	Details